Crossmark

Influence of baseline MELD score in the efficacy of treatment of hepatitis C with simeprevir and sofosbuvir

Crossref DOI link: https://doi.org/10.1016/j.eimce.2018.03.002

Published Print: 2018-05

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Moreno-Planas, José María

Larrubia-Marfil, Juan Ramón

Sánchez-Ruano, Juan José

Morillas-Ariño, Julia

Patón-Arenas, Roberto

Sáiz-Chumillas, Rosa María

Tébar-Romero, Emilia

Lucendo-Villarín, Alfredo

Gancedo-Bringas, Pilar

Solera-Muñoz, Mario

Vicente-Gutiérrez, María del Mar

Martínez-Alfaro, Elisa
License Information

Text and Data Mining valid from 2018-05-01
More Information

This article is maintained by: Elsevier

Article Title: Influence of baseline MELD score in the efficacy of treatment of hepatitis C with simeprevir and sofosbuvir

Journal Title: Enfermedades infecciosas y microbiologia clinica (English ed.)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.eimce.2018.03.002

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.eimc.2017.05.001

Content Type: article

Copyright: © 2017 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.